Some doctors are threatening to stop seeing Medicare patients if Congress goes through with cutting doctors fees more than 10 percent. Nancy Marshall Genzer reports both sides of the debate have taken to the TV airwaves.
The American Academy of Pediatrics is recommending that kids as young as 8 take drugs to lower their cholesterol if diets don't work. Nancy Marshall Genzer reports on whether kids might be the next big market for Big Pharma.
A team of Japanese doctors say they have perfected a technique that could make conventional implants obsolete. But as Lucy Craft reports from Tokyo, beauty comes at a cost.
Tomato growers have millions and consumers are shaken, but there are still no answers. Host Bob Moon asks analyst J.D. Hanson why there's been no word on the source of the outbreak.
Gas prices are making many home care workers with severe patient commutes consider a new line of work. Michael Caputo looks into the collective number of miles these workers drive and what could be a possible solution.
Medicare is preparing to make medical supply companies compete against each other on prices. But as host Bob Moon learns from New York Times business columnist David Leonhardt, there may be a fight ahead.
With food becoming more expensive, people are reconsidering their food choices at the grocery store — and what they buy could end up being healthier in the long run. Janet Babin reports.
Lipitor is the world's best-selling drug, but Pfizer, the maker of the cholesterol medication, has a strong patent protecting it against generics. A new agreement will change that in a few years. Janet Babin reports.
It's got a big name — bapineuzumab — but a new Alzheimer's drug could also have a big payoff. With projections in the billions, it could be the highest grossing drug in history. Janet Babin reports.
